Adoption of a National Prophylactic Anticoagulation Guideline for Hospitalized Pregnant Women With COVID-19: Retrospective Cohort Study

BACKGROUND: Both COVID-19 and pregnancy are associated with hypercoagulability. Due to the increased risk for thrombosis, the United States National Institute of Health’s recommendation for prophylactic anticoagulant use for pregnant patients has expanded from patients hospitalized for severe COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Yeon-Mi, Piekos, Samantha, Sorensen, Tanya, Hood, Leroy, Hadlock, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389076/
https://www.ncbi.nlm.nih.gov/pubmed/37311123
http://dx.doi.org/10.2196/45586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389076/
https://www.ncbi.nlm.nih.gov/pubmed/37311123
http://dx.doi.org/10.2196/45586

Ejemplares similares